A Prospective, Randomized Trial Of Simultaneous Pancreatic Cancer Treatment With Enoxaparin and ChemoTherapy (PROSPECT).

Trial Profile

A Prospective, Randomized Trial Of Simultaneous Pancreatic Cancer Treatment With Enoxaparin and ChemoTherapy (PROSPECT).

Completed
Phase of Trial: Phase II/III

Latest Information Update: 12 Jan 2015

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Thromboembolism; Venous thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PROSPECT
  • Most Recent Events

    • 04 Jun 2010 Final results presented at the 46th Annual Meeting of the American Society of Clinical Oncology.
    • 20 Sep 2009 Results presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology.
    • 29 May 2009 Results presented at ASCO 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top